12th week of 2022 patent applcation highlights part 26 |
Patent application number | Title | Published |
20220089598 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | 2022-03-24 |
20220089599 | ALKYNYL NICOTINAMIDE COMPOUNDS AS KINASE INHIBITORS | 2022-03-24 |
20220089600 | TGF INHIBITOR AND PRODRUGS | 2022-03-24 |
20220089601 | SOLID FORMS OF TTK INHIBITOR | 2022-03-24 |
20220089602 | COMPOUNDS THAT INDUCE FERROPTIC CELL DEATH | 2022-03-24 |
20220089603 | COMPOUND USED AS KINASE INHIBITOR AND APPLICATION THEREOF | 2022-03-24 |
20220089604 | HETEROCYCLIC COMPOUND, HOLE TRANSPORT COMPOSITION INCLUDING THE SAME, LIGHT-EMITTING DEVICE INCLUDING THE HOLE TRANSPORT COMPOSITION, METHOD OF MANUFACTURING THE LIGHT-EMITTING DEVICE, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | 2022-03-24 |
20220089605 | NOVEL MORPHINANS USEFUL FOR TREATING MEDICAL DISORDERS | 2022-03-24 |
20220089606 | Biologically Active Taxane Analogs and Methods of Treatment by Oral Administration | 2022-03-24 |
20220089607 | PROCESS FOR THE PREPARATION OF HIGH PURE ERIBULIN AND ITS MESYLATE SALT | 2022-03-24 |
20220089608 | CDK Inhibitors And Their Use As Pharmaceuticals | 2022-03-24 |
20220089609 | SUBSTITUTED QUINAZOLINONE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR4 | 2022-03-24 |
20220089610 | POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | 2022-03-24 |
20220089611 | INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 AND USES THEREOF | 2022-03-24 |
20220089612 | HETEROCYCLIC COMPOUNDS AS PRMT5 INHIBITORS | 2022-03-24 |
20220089613 | NOVEL 3-AMINO-PYRROLO[3,4-C]PYRAZOLE-5(1H, 4H,6H) CARBALDEHYDE DERIVATIVES | 2022-03-24 |
20220089614 | SODIUM SQUARATE HEXAHYDRATE COMPLEX | 2022-03-24 |
20220089615 | PHOTOSENSITIZER COMPOUNDS, METHODS OF MANUFACTURE AND APPLICATION TO PLANTS | 2022-03-24 |
20220089616 | CARBORANE-BASED HISTONE DEACETYLASE (HDAC) INHIBITORS | 2022-03-24 |
20220089617 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 2022-03-24 |
20220089618 | Solid-State Synthesis Of Precursors Of Metal-Organic Frameworks | 2022-03-24 |
20220089619 | SYNTHESIS STRATEGY FOR GAP PROTECTING GROUP | 2022-03-24 |
20220089620 | INHIBITORS OF THE ENZYME ENOLASE FOR PRECISION ONCOLOGY | 2022-03-24 |
20220089621 | THIAMINE COMPOUND, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITION THEREOF | 2022-03-24 |
20220089622 | PROTEIN PROXIMITY ASSAY IN FORMALIN FIXED PARAFFIN EMBEDDED TISSUE USING CAGED HAPTENS | 2022-03-24 |
20220089623 | DIPHOSPHITES HAVING AN OPEN, 2,4-METHYLATED OUTER UNIT | 2022-03-24 |
20220089624 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | 2022-03-24 |
20220089625 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | 2022-03-24 |
20220089626 | COMPOUNDS AND METHODS FOR THE TREATMENT OF PATHOGENIC NEISSERIA | 2022-03-24 |
20220089627 | STAPHYLOCOCCUS AUREUS TYPE 8 CAPSULAR SACCHARIDES | 2022-03-24 |
20220089628 | FORMULATION AND METHOD FOR SPRAY-DRYING D-TAGATOSE | 2022-03-24 |
20220089629 | AMORPHOUS SIALYLATED OLIGOSACCHARIDES | 2022-03-24 |
20220089630 | ELECTROCATALYTIC SYNTHESIS OF DIHYDROCHALCONES | 2022-03-24 |
20220089631 | COMPOUND COMPRISING MULTIVALENT SIALYLOLIGOSACCHARIDE RESIDUES, AND COMPOSITION FOR PREVENTING OR TREATING VIRAL INFECTION DISEASES, CONTAINING SAME AS ACTIVE INGREDIENT | 2022-03-24 |
20220089632 | NOVEL BICYCLIC NUCLEOSIDES AND OLIGOMERS PREPARED THEREFROM | 2022-03-24 |
20220089633 | HETEROBIFUNCTIONAL INHIBITORS OF E-SELECTIN AND GALECTIN-3 | 2022-03-24 |
20220089634 | ARTIFICIAL NUCLEIC ACID, PRODUCTION METHOD THEREFOR, AND USE THEREOF | 2022-03-24 |
20220089635 | CRYSTALLINE FORMS OF DEXAMETHASONE DIMERS AND USES THEREOF | 2022-03-24 |
20220089636 | TETRAZOLONE SUBSTITUTED STEROIDS AND USE THEREOF | 2022-03-24 |
20220089637 | STEROID COMPOUND, AND USE THEREOF AND PREPARATION METHOD THEREFOR | 2022-03-24 |
20220089638 | DITHIOCARBAMATE STAPLED PEPTIDES AND METHODS OF MAKING AND USE THEREOF | 2022-03-24 |
20220089639 | SITE-SPECIFIC CHEMOENZYMATIC PROTEIN MODIFICATIONS | 2022-03-24 |
20220089640 | CYCLIC POLYPEPTIDES FOR PCSK9 INHIBITION | 2022-03-24 |
20220089641 | Carrier Peptide Fragment and Use Thereof | 2022-03-24 |
20220089642 | Fc Receptor-ACE2 Conjugates and Use Thereof | 2022-03-24 |
20220089643 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NECTIN-4 | 2022-03-24 |
20220089644 | C1q AND HMGB1 FUSION PROTEINS AND USES THEREOF | 2022-03-24 |
20220089645 | PHARMACEUTICAL COMPOSITION AND THE USE THEREOF IN THE TREATMENT OF AUTOIMMUNE DISEASES | 2022-03-24 |
20220089646 | A CYCLIC PEPTIDE | 2022-03-24 |
20220089647 | CYCLIC PEPTIDE, CELL SCAFFOLD MATERIAL, CELL SEPARATING MATERIAL, AND MEDIUM | 2022-03-24 |
20220089648 | SCALABLE FERMENTATION PROCESS | 2022-03-24 |
20220089649 | Method for Extracting Hepatitis A Virus (HAV) Antigen from Cell Culture | 2022-03-24 |
20220089650 | METHODS AND COMPOSITIONS FOR DELIVERY OF AGENTS ACROSS THE BLOOD-BRAIN BARRIER | 2022-03-24 |
20220089651 | METHODS AND COMPOSITIONS FOR ANTIBODY-EVADING VIRUS VECTORS | 2022-03-24 |
20220089652 | STABILIZED SOLUBLE PRE-FUSION RSV F PROTEINS | 2022-03-24 |
20220089653 | MICROBIALLY DERIVED PEPTIDES AND PROTEINS FOR IMMUNOTHERAPY | 2022-03-24 |
20220089654 | MUTANT TRANSPORTERS FOR BACTERIAL UPTAKE OF TEREPHTHALIC ACID | 2022-03-24 |
20220089655 | NOVEL POLYPEPTIDE-MODIFYING ENZYMES AND USES THEREOF | 2022-03-24 |
20220089656 | PROTEIN M FUSION PROTEINS AND USES | 2022-03-24 |
20220089657 | MODIFIED PEPTIDES | 2022-03-24 |
20220089658 | COMPOSITIONS AND METHODS FOR CONTROLLING INSECT PESTS | 2022-03-24 |
20220089659 | MESOPHILIC ARGONAUTE SYSTEMS AND USES THEREOF | 2022-03-24 |
20220089660 | IDENTIFICATION OF MUTATIONS IN CHANNELOPSIN VARIANTS HAVING IMPROVED LIGHT SENSITIVITY AND METHODS OF USE THEREOF | 2022-03-24 |
20220089661 | ANTIMICROBIAL PEPTIDES | 2022-03-24 |
20220089662 | PREPRATION METHOD AND APPLICATION OF ANTI-INFLAMMATORY KIDNEY PROTECTING CLAM PEPTIDE | 2022-03-24 |
20220089663 | PROTEINS AND FLUOROPHORE-CONTAINING COMPOUNDS SELECTIVE FOR NaV1.7 | 2022-03-24 |
20220089664 | Treatment Of Ophthalmic Conditions With Angiopoietin-Like 7 (ANGPTL7) Inhibitors | 2022-03-24 |
20220089665 | Peptide Compounds and Methods of Use in Wound Healing | 2022-03-24 |
20220089666 | COMPOSITIONS, FORMULATIONS AND INTERLEUKIN PRODUCTION AND PURIFICATION | 2022-03-24 |
20220089667 | Polypeptides Comprising Modified IL-2 Polypeptides and Uses Thereof | 2022-03-24 |
20220089668 | TARGETED MUTANT INTERFERON-BETA AND USES THEREOF | 2022-03-24 |
20220089669 | GLUCAGON LIKE PEPTIDE 1 (GLP1)-GROWTH DIFFERENTIATION FACTOR 15 (GDF15) FUSION PROTEINS AND USES THEREOF | 2022-03-24 |
20220089670 | Gene Therapy for BEST1 Dominant Mutations | 2022-03-24 |
20220089671 | TRANSPOSON-BASED TRANSFECTION SYSTEM FOR PRIMARY CELLS | 2022-03-24 |
20220089672 | T-CELL RECEPTOR MODIFIED OBJECT | 2022-03-24 |
20220089673 | HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION | 2022-03-24 |
20220089674 | ENGINEERED IMMUNE CELLS THAT MODULATE RECEPTOR EXPRESSION | 2022-03-24 |
20220089675 | ENGINEERED IMMUNE CELLS WITH DOMINANT SIGNALS | 2022-03-24 |
20220089676 | ENGINEERED IMMUNE CELLS WITH RECEPTOR SIGNAL STRENGTH MODULATED BY A HINGE | 2022-03-24 |
20220089677 | ANTI-KRAS-G12D T CELL RECEPTORS | 2022-03-24 |
20220089678 | ANTI-BCMA CHIMERIC ANTIGEN RECEPTORS | 2022-03-24 |
20220089679 | FUSION PROTEIN WITH IMMUNOSUPPRESSIVE ACTIVITY | 2022-03-24 |
20220089680 | MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF | 2022-03-24 |
20220089681 | METHODS FOR MODULATING AN IMMUNE RESPONSE | 2022-03-24 |
20220089682 | METHODS OF TREATING LIVER DISEASE | 2022-03-24 |
20220089683 | BI-AND TRI-FUNCTIONAL FUSION PROTEINS AND USES THEREOF | 2022-03-24 |
20220089684 | TYPE 1 INTERFERON NEUTRALIZING FC-FUSION PROTEIN AND USE THEREOF | 2022-03-24 |
20220089685 | RED BLOOD CELL TARGETED FACTOR VIII AND METHOD OF USING THE SAME | 2022-03-24 |
20220089686 | FUSION PROTEIN AND HIGH-DENSITY LIPOPROTEIN MEASUREMENT KIT USING SAME | 2022-03-24 |
20220089687 | POLYNUCLEOTIDES ENCODING APOA1-PON1 FUSION POLYPEPTIDES | 2022-03-24 |
20220089688 | NUCLEIC ACIDS ENCODING A TN3 SCAFFOLD COMPRISING A CD40L-SPECIFIC MONOMER SUBUNIT | 2022-03-24 |
20220089689 | VARIANTS OF TISSUE INHIBITOR OF METALLOPROTEINASE TYPE THREE (TIMP-3), COMPOSITIONS AND METHODS | 2022-03-24 |
20220089690 | METHOD FOR LARGE SCALE PRODUCTION OF ANTIBODIES USING A CELL-FREE PROTEIN SYNTHESIS SYSTEM | 2022-03-24 |
20220089691 | ANTI-SARS-COV-2 ANTIBODIES AND APPLICATION THEREOF | 2022-03-24 |
20220089692 | NANO-ANTIBODY AND ITS APPLICATION BASED ON SARS-COV-2 S PROTEIN S1 SUBUNIT | 2022-03-24 |
20220089693 | NANO-ANTIBODY AND ITS APPLICATION BASED ON SARS-COV-2 S PROTEIN | 2022-03-24 |
20220089694 | EBOLA VIRUS GLYCOPROTEIN-SPECIFIC MONOCLONAL ANTIBODIES AND USES THEREOF | 2022-03-24 |
20220089695 | Targeting SARS-CoV-2 Viral-immune Interaction for COVID-19 Therapy | 2022-03-24 |
20220089696 | ARENAVIRUS MONOCLONAL ANTIBODIES AND USES | 2022-03-24 |
20220089697 | MONOCLONAL ANTIBODY OR ANTIGEN BINDING FRAGMENT THEREOF THAT BINDS TO THE L PROTEIN OF THE HUMAN PARAINFLUENZA VIRUS (PIV); METHOD AND KIT FOR DETECTING PIV | 2022-03-24 |